ZiP Diagnostics is bringing a high sensitivity molecular test for
SARS-CoV-2, to domestic high-volume production.
The ZiP-CoVx test is a point-of-care molecular diagnostic technology that combines its test instruments and assay (swab and cartridge with reagents) manufacturing capacity.
The advantages of this system include:
Direct detection of current SARS-CoV-2 viral infection
Sample type includes nasal, nasal-pharyngeal or throat swab with direct insertion into sealed cartridge (saliva sample type in development).
Test result within 15 to 30 minutes with high sensitivity comparable to PCR.
Simple work flow
Low cost test, significantly less than existing laboratory tests (order volume dependant).
Site management software provides secure, encrypted records and management of workflow, site administration, sample collection and test instruments.